Literature DB >> 2177788

A physiological model for renal drug metabolism: enalapril esterolysis to enalaprilat in the isolated perfused rat kidney.

I A de Lannoy1, H Hirayama, K S Pang.   

Abstract

A physiologically based kidney model was developed to describe the metabolism of enalapril and explain the observed discrepancies between generated and preformed enalaprilat (metabolite) elimination in the constant flow single-pass and recirculating isolated perfused rat kidney preparations (IPKs) as a result of the differing points of origin of the metabolite within the kidney, subsequent to the simultaneous delivery of 14C-enalapril and 3H-enalaprilat. The model incorporated clearances for diffusion/transport of drug and metabolite across the basolateral and luminal membranes of the renal cells, an intrinsic clearance for renal drug metabolism, in addition to physiological variables such as perfusate flow rate, glomerular filtration rate, and urine flow rate. Nonlinear curve fitting of single-pass and recirculating data was performed to estimate the rate-limiting step in the renal elimination of enalaprilat. Through fitting and simulation procedures, we were able to predict metabolic and excretory events for enalapril (renal extraction ratio approximately equal to 0.25-0.3; fractional excretion, FE, was less than unity) and the relatively constant pattern of urinary excretion of preformed enalaprilat (extraction ratio approximately equal to 0.07; FE approximately equal to 1). The extraction ratio of the intrarenally formed enalaprilat in single-pass IPK was about twofold that for the preformed metabolite, whereas the FEs of generated enalaprilat in recirculating IPKs were greater than 1, and tended to increase, then decrease with perfusion time. These observations were explained by the optimized parameters which indicated that efflux from cell to lumen was rate-controlling in the excretion of enalaprilat, and another small transport barrier also existed at the basolateral membrane; the lower extraction ratio of preformed enalaprilat was due to its poor transmembrane clearance at the basolateral membrane. The variable FEs for generated enalaprilat vs. the relatively constant FE for preformed metabolite in the recirculating IPK was explained by the changing contributions of both circulating and intrarenal metabolite to metabolite excretion.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2177788     DOI: 10.1007/BF01073939

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


  28 in total

1.  Renal handling of enalapril and enalaprilat: studies in the isolated red blood cell-perfused rat kidney.

Authors:  I A de Lannoy; R Nespeca; K S Pang
Journal:  J Pharmacol Exp Ther       Date:  1989-12       Impact factor: 4.030

2.  Na+-dependent p-aminohippurate transport at the basolateral side of the isolated perfused rat kidney.

Authors:  N Itoh; Y Sawada; Y Sugiyama; T Iga; M Hanano
Journal:  Biochim Biophys Acta       Date:  1986-09-11

3.  Metabolism of drugs by the kidney.

Authors:  M W Anders
Journal:  Kidney Int       Date:  1980-11       Impact factor: 10.612

4.  Role of renal metabolism and excretion in 5-nitrofuran-induced uroepithelial cancer in the rat.

Authors:  L A Spry; T V Zenser; S M Cohen; B B Davis
Journal:  J Clin Invest       Date:  1985-09       Impact factor: 14.808

5.  Relationship between para-aminohippurate secretion and cellular morphology in rabbit proximal tubules.

Authors:  P B Woodhall; C C Tisher; C A Simonton; R R Robinson
Journal:  J Clin Invest       Date:  1978-05       Impact factor: 14.808

6.  Kinetic modeling of the renal excretion of iodopyracet in the dog.

Authors:  P Hekman; C A van Ginneken
Journal:  J Pharmacokinet Biopharm       Date:  1982-02

7.  Selective vulnerability of the medullary thick ascending limb to anoxia in the isolated perfused rat kidney.

Authors:  M Brezis; S Rosen; P Silva; F H Epstein
Journal:  J Clin Invest       Date:  1984-01       Impact factor: 14.808

8.  Urine flow-dependence and interspecies variation of the renal reabsorption of sulfanilamide.

Authors:  I Komiya
Journal:  J Pharmacobiodyn       Date:  1987-01

9.  Physiologically based pharmacokinetic model for the renal clearance of salicyluric acid and the interaction with phenolsulfonphthalein in the dog.

Authors:  F G Russel; A C Wouterse; C A van Ginneken
Journal:  Drug Metab Dispos       Date:  1987 Sep-Oct       Impact factor: 3.922

10.  Basis for heterogeneity of para-aminohippurate secretion in rabbit proximal tubules.

Authors:  A Shimomura; A M Chonko; J J Grantham
Journal:  Am J Physiol       Date:  1981-05
View more
  8 in total

1.  Physiological modeling of drug and metabolite: disposition of oxazepam and oxazepam glucuronides in the recirculating perfused mouse liver preparation.

Authors:  M V St-Pierre; D van den Berg; K S Pang
Journal:  J Pharmacokinet Biopharm       Date:  1990-10

Review 2.  Advanced pharmacokinetic models based on organ clearance, circulatory, and fractal concepts.

Authors:  K Sandy Pang; Michael Weiss; Panos Macheras
Journal:  AAPS J       Date:  2007-06-29       Impact factor: 4.009

3.  Organ clearance concepts: new perspectives on old principles.

Authors:  G L Sirianni; K S Pang
Journal:  J Pharmacokinet Biopharm       Date:  1997-08

Review 4.  Drug interactions at the renal level. Implications for drug development.

Authors:  P L Bonate; K Reith; S Weir
Journal:  Clin Pharmacokinet       Date:  1998-05       Impact factor: 6.447

Review 5.  Key to Opening Kidney for In Vitro-In Vivo Extrapolation Entrance in Health and Disease: Part II: Mechanistic Models and In Vitro-In Vivo Extrapolation.

Authors:  Daniel Scotcher; Christopher Jones; Maria Posada; Aleksandra Galetin; Amin Rostami-Hodjegan
Journal:  AAPS J       Date:  2016-08-09       Impact factor: 4.009

6.  Formed and preformed metabolite excretion clearances in liver, a metabolite formation organ: studies on enalapril and enalaprilat in the single-pass and recirculating perfused rat liver.

Authors:  I A de Lannoy; F Barker; K S Pang
Journal:  J Pharmacokinet Biopharm       Date:  1993-08

7.  Combined recirculation of the rat liver and kidney: studies with enalapril and enalaprilat.

Authors:  I A de Lannoy; K S Pang
Journal:  J Pharmacokinet Biopharm       Date:  1993-08

8.  Human physiologically based pharmacokinetic model for ACE inhibitors: ramipril and ramiprilat.

Authors:  David G Levitt; Rik C Schoemaker
Journal:  BMC Clin Pharmacol       Date:  2006-01-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.